Physician profile
Michele Thomas
NPI 1902862436
$6,330.47
in general payments reported to CMS, 2019-2025
31 companies · $91.54 in 2025
The $91.54 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $410 · 2021: $925 · 2022: $2,157 · 2023: $1,669 · 2024: $518 · 2025: $91.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,375 · Food and Beverage: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,375.00 |
| Food and Beverage | $903.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $2,863.47 | 2021-2024 | Nexplanon |
| Abbvie INC. | $655.25 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Aspira Women'S Health INC | $377.97 | 2020-2022 | |
| Hologic Sales and Service, LLC | $312.93 | 2019-2025 | Acessa Provu System, Fluent Fluid Management System |
| Sumitomo Pharma America, INC. | $262.09 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $249.27 | 2021-2022 | |
| Inari Medical, INC. | $167.50 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Daiichi Sankyo INC. | $154.78 | 2019-2022 | |
| Avion Pharmaceuticals | $140.73 | 2019-2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $133.96 | 2021-2023 | |
| Pfizer INC. | $125.34 | 2021-2024 | |
| Amarin Pharma, INC. | $123.24 | 2019 | |
| Merck Sharp & Dohme LLC | $104.61 | 2019-2021 | |
| Therapeuticsmd, INC. | $103.27 | 2019-2022 | |
| Lupin INC. | $88.98 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $76.30 | 2019-2022 | |
| Scynexis, INC. | $51.22 | 2021-2022 | |
| Astellas Pharma US INC | $50.84 | 2024-2025 | Veozah |
| Evofem Biosciences, INC. | $42.60 | 2021 | |
| Millicent US INC | $35.32 | 2024-2025 | Intrarosa, Femring |
| Mission Pharmacal Company | $34.27 | 2020-2021 | |
| Medtronic, INC. | $25.25 | 2022 | |
| Smith+Nephew, INC. | $22.12 | 2023 | Stravix Pl |
| Takeda Pharmaceuticals U.S.A., INC. | $20.21 | 2024 | Vpriv |
| Shield Therapeutics INC | $19.26 | 2023 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $18.01 | 2021 | |
| Coopersurgical, INC. | $16.37 | 2020 | |
| Exeltis, USA INC. | $15.34 | 2019 | |
| Agile Therapeutics, INC. | $14.87 | 2021 | |
| Baxter Healthcare | $13.72 | 2025 | Perclot |
| Acessa Health INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.